| The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse ER Wright, HE Kooreman, MS Greene, RA Chambers, A Banerjee, ... Drug and alcohol dependence 138, 209-215, 2014 | 102 | 2014 |
| Pseudoaddiction: fact or fiction? An investigation of the medical literature MS Greene, RA Chambers Current addiction reports 2, 310-317, 2015 | 77 | 2015 |
| Fentanyl related overdose in Indianapolis: Estimating trends using multilevel Bayesian models P Phalen, B Ray, DP Watson, P Huynh, MS Greene Addictive behaviors 86, 4-10, 2018 | 41 | 2018 |
| Prescription drug monitoring program inquiry in psychiatric assessment: detection of high rates of opioid prescribing to a dual diagnosis population DT Hackman, MS Greene, TJ Fernandes, AM Brown, ER Wright, ... The Journal of clinical psychiatry 75 (7), 15316, 2014 | 19 | 2014 |
| Measuring rurality in health services research: a scoping review R Danek, J Blackburn, M Greene, O Mazurenko, N Menachemi BMC Health Services Research 22 (1), 1340, 2022 | 14 | 2022 |
| Opioid-related emergency department encounters: patient, encounter, and community characteristics associated with repeated encounters CP Balio, KK Wiley Jr, MS Greene, JR Vest Annals of emergency medicine 75 (5), 568-575, 2020 | 14 | 2020 |
| Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexone A Sajid, A Whiteman, RL Bell, MS Greene, EA Engleman, RA Chambers The American journal on addictions 25 (7), 557-564, 2016 | 13 | 2016 |
| Assessment of risk behaviors in patients with opioid prescriptions: A study of Indiana's inspect data MS Greene, RA Chambers, CT Yiannoutsos, ER Wright, GK Steele, ... The American journal on addictions 26 (8), 822-829, 2017 | 8 | 2017 |
| Injection drug use in Indiana: a major risk for HIV transmission H Kooreman, M Greene Richard M. Fairbanks School of Public Health, 2016 | 8 | 2016 |
| Contemporary trends in hospitalizations for comorbid chronic liver disease and substance use disorders AP Desai, M Greene, LD Nephew, ES Orman, M Ghabril, N Chalasani, ... Clinical and translational gastroenterology 12 (6), e00372, 2021 | 7 | 2021 |
| The changing landscape of the opioid epidemic in Marion County and evidence for action D Watson, J Duwve, M Greene, T Weathers, P Huynh, R Nannery Richard M. Fairbanks School of Public Health, 2018 | 4 | 2018 |
| Substance abuse trends in Indiana: A 10-year perspective C Balio, M Greene Richard M. Fairbanks School of Public Health, 2017 | 4 | 2017 |
| Mental health, substance misuse, and suicide: Shared risk and protective factors K Hilts, MS Greene The Center for Health Policy, 2018 | 3 | 2018 |
| Adverse Childhood Experiences (ACEs) and Their Impact on Substance Misuse & Overall Health C Balio, MS Greene The Center for Health Policy, 2018 | 3 | 2018 |
| Polypharmacy among prescription drug users I Omenka, MS Greene The Center for Health Policy, 2017 | 3 | 2017 |
| Injection drug use in indiana M Greene, A Aiypkhanova, O Aladejebi, E Wright IUPUI (Campus). Center for Health Policy, 2010 | 3 | 2010 |
| Substance abuse in Indiana: An urban-rural perspective HE Kooreman, MS Greene The Center for Health Policy, 2017 | 2 | 2017 |
| Opioid treatment programs in Indiana M Williams, M Greene, E Wright IUPUI (Campus). Center for Health Policy, 2013 | 2 | 2013 |
| The Economic Impact of Substance Misuse and Abuse in Indiana E Wright, M Greene, Y Li, AM Judson-Patrick IUPUI (Campus). Center for Health Policy, 2010 | 2 | 2010 |
| Oral health needs in Indiana: developing an effective and diverse workforce O Aguirre-Zero, M Greene, ER Wright Journal (Indiana Dental Association) 88 (4), 6-13, 2009 | 2 | 2009 |
